Skip to main content
Filing year 2024

Marco Dementia Respite MDR Inc

Marco Island, Florida·EIN 92-1678816·NTEE G01 · Diseases, Disorders & Medical Disciplines·3
Total revenue
$476k
Total assets
$724k
Total expenses
$187k
Reported officers
8
Mission

Developing and providing supportive, stimulating, educational, and clinical services for individuals with early stage Alzheimer's and dementia, their caregivers, and other adults in need. Mission is to enhance quality of life through compassion and innovative programs that address the unique challenges faced by those living with dementia and their families.

Reported officers (all unpaid)

No paid executives reported in 2024. Marco Dementia Respite MDR Inc reported 8 unpaid officers and board members on its 990.

Chairman
Director
Director
Director
Director
Director
Director
Treasurer
Financial trend

Revenue and expenses over time

Marco Dementia Respite MDR Inc reported revenue and expenses across 2 filing years.

RevenueExpenses
$531k
$138k
2023
$476k
$187k
2024
Total revenue and total expenses from IRS Form 990 filings.
Sector benchmark

What Diseases, Disorders & Medical Disciplines executives earn

Marco Dementia Respite MDR Inc reported no executive compensation in its latest filing. For context, the highest-paid executive at a comparable diseases, disorders & medical disciplines organization nationwide earns a median of $89,225.

25th percentile
$42k
Median
$89,225
75th percentile
$171k
90th percentile
$311k

These are diseases, disorders & medical disciplines sector-wide figures, not this organization's reported pay. Based on 619 organizations across 619 filings (2021 – 2023).

See full Diseases, Disorders & Medical Disciplines compensation data
Free, forever
Build lists. Save your benchmarks.
A free Lucido account lets you build lists of nonprofits and save your search filters. No credit card.
Create free account
Already a member? Sign in
Build a benchmark

Compare any role, sector, or revenue band

Build your own benchmark from millions of reported positions.